Endonatura Labs

Endonatura Labs is a Barcelona-based biotechnology company specializing in the development of natural modulators for the endocannabinoid system (ECS) to address metabolic diseases. The company utilizes its proprietary "Endo-Screen" platform to identify and optimize plant-derived compounds that target peripheral ECS receptors, aiming to regulate appetite and energy expenditure without central nervous system side effects. Their primary focus is on treating obesity and metabolic syndrome through non-synthetic, evidence-based therapeutic interventions. Endonatura's approach combines traditional ethnobotany with modern pharmacological screening to create a new class of metabolic health solutions. The company is currently advancing its lead candidates through pre-clinical validation to establish a pipeline of safe and effective metabolic regulators.